Liver Regeneration After Liver Resection

Sponsor
Nottingham University Hospitals NHS Trust (Other)
Overall Status
Unknown status
CT.gov ID
NCT01220986
Collaborator
(none)
20
1
24
0.8

Study Details

Study Description

Brief Summary

The aim of this study is to characterize Kupffer cell activity and activation of the innate immune response in the early phase of liver regeneration after right hepatectomy. The investigators hypothesise that liver regeneration after right hepatectomy in humans is associated with Kupffer cell activation and initiation of the innate immune response and that impaired liver regeneration, liver failure and sepsis following liver resection are associated with Kupffer cell dysfunction and an impaired innate immune response. The objectives for this study are to characterise Kupffer cell activity and the innate immune response in human liver before and after right hepatectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Liver biopsy

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
An Observational Study of Liver Regeneration After Right Hepatectomy: Understanding the Molecular Primers of Liver Regeneration
Study Start Date :
Aug 1, 2010
Anticipated Primary Completion Date :
Dec 1, 2011
Anticipated Study Completion Date :
Aug 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Right hepatectomy

Intervals from inflow division.

Procedure: Liver biopsy
0, 30, 60, 90 min post inflow-division

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients requiring right hepatectomy for colorectal liver metastases
    Exclusion Criteria:
    • Age >75, neoadjuvant chemotherapy, recurrent disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Nottingham University Hospitals NHS Trust, Queens Medical Centre Campus Nottingham Nottinghamshire United Kingdom NG7 2UH

    Sponsors and Collaborators

    • Nottingham University Hospitals NHS Trust

    Investigators

    • Study Chair: Dileep N. Lobo, DM FRCS, Reader in Surgery

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01220986
    Other Study ID Numbers:
    • NDDC10/H0403/32
    First Posted:
    Oct 14, 2010
    Last Update Posted:
    Oct 14, 2010
    Last Verified:
    Oct 1, 2010
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 14, 2010